AKEBIA THERAPEUTICS INC (AKBA)
US00972D1054 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -43.69M | -51.92M | -92.56M | -282.84M | -383.46M | |||
| Depreciation Amortization | 37.59M | 37.63M | 37.69M | 37.97M | 33.60M | |||
| Change In Working Capital | -32.03M | -20.73M | -10.99M | -108.42M | -13.67M | |||
| Interest Paid | N/A | 6.06M | 6.76M | 9.63M | N/A | |||
| Other non cash items | 12.86M | 11.64M | -7.30M | 100.32M | 253.15M | |||
| OPERATING CASH FLOW | -25.28M | -23.38M | -73.15M | -252.97M | -110.39M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -110.00K | -60.00K | -320.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | 40.00M | -39.69M | |||
| INVESTING CASH FLOW | N/A | 0.00 | -110.00K | 39.94M | -40.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -15.73M | -32.00M | -33.00M | 0.00 | 19.98M | |||
| Stock Issued/Repurchased | 25.71M | 6.79M | 7.60M | 88.95M | 211.75M | |||
| Other Financing Activity | -750.00K | 0.00 | 40.00M | 44.78M | N/A | |||
| FINANCING CASH FLOW | 9.24M | -25.21M | 14.60M | 133.73M | 231.72M | |||
| CHANGE IN CASH | -16.04M | -48.59M | -58.66M | -79.30M | 81.33M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.28M | -23.38M | -73.15M | -252.97M | -110.39M | |||
| Capital Expenditure | N/A | 0.00 | -110.00K | -60.00K | -320.00K | |||
| FREE CASH FLOW | -25.28M | -23.38M | -73.26M | -253.03M | -110.71M | |||
All data in USD